Biopharma Sustainability Roundtable
“We quickly realized how valuable the Biopharma Sustainability Roundtable was. We found it highly relevant, with discussions that provided valuable information on topics we are working on right now. The open exchange with our peers helps us to better understand opportunities and challenges in pursuing our sustainability work.”
The Biopharma Sustainability Roundtable (BSRT) is an independent sector-specific network created to connect and support senior biotech and pharma leaders who are driving the biopharma sustainability agenda forward. Our participants are leading biotech and pharma companies operating globally.
The BSRT organizes, facilitates, and delivers an annual program of online topical forums, peer-to-peer networks, initiatives, in-person meetings, and bespoke advisory services. The annual program addresses a wide range of global environmental, social, and governance (ESG) topics, from strategy through governance, targets and performance, operations, and reporting. Annual themes and content are driven by the sector’s current and emerging priorities and are developed in consultation with participating companies.
BSRT background and overview, including biopharma and investor participation, range of agenda, and participant experience
Biopharma Participation
Biopharma Sustainability Roundtable participation includes a wide range of companies, represented by senior level executives with strategic and operational responsibility for Sustainability, Corporate Responsibility, or ESG.
Past Participants
(acquired by AstraZeneca)
(acquired by BMS)
(acquired by AstraZeneca)
(Part of Merck KGaA)
(acquired by Takeda)